Axsome Therapeutics, Inc. (AXSM)
USD 97.55
(-0.96%)
USD 97.55
(-0.96%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 397.25 Million USD | 79.01% |
| 2022 | 221.91 Million USD | 213.26% |
| 2021 | 70.84 Million USD | -2.07% |
| 2020 | 72.34 Million USD | 72.95% |
| 2019 | 41.82 Million USD | 189.64% |
| 2018 | 14.44 Million USD | -23.34% |
| 2017 | 18.83 Million USD | 13.2% |
| 2016 | 16.64 Million USD | 532.29% |
| 2015 | 2.63 Million USD | -56.05% |
| 2014 | 5.98 Million USD | 45.18% |
| 2013 | 4.12 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 445.37 Million USD | 10.87% |
| 2024 Q1 | 401.69 Million USD | 1.12% |
| 2023 FY | 397.25 Million USD | 79.01% |
| 2023 Q2 | 332.83 Million USD | 20.0% |
| 2023 Q1 | 277.36 Million USD | 24.99% |
| 2023 Q4 | 397.25 Million USD | 19.89% |
| 2023 Q3 | 331.34 Million USD | -0.45% |
| 2022 Q1 | 73.86 Million USD | 4.26% |
| 2022 FY | 221.91 Million USD | 213.26% |
| 2022 Q4 | 221.91 Million USD | 22.2% |
| 2022 Q3 | 181.59 Million USD | 9.82% |
| 2022 Q2 | 165.35 Million USD | 123.88% |
| 2021 Q4 | 70.84 Million USD | -4.11% |
| 2021 Q1 | 70.61 Million USD | -2.39% |
| 2021 Q3 | 73.88 Million USD | 2.86% |
| 2021 Q2 | 71.82 Million USD | 1.72% |
| 2021 FY | 70.84 Million USD | -2.07% |
| 2020 Q3 | 68.36 Million USD | 86.05% |
| 2020 FY | 72.34 Million USD | 72.95% |
| 2020 Q1 | 41.64 Million USD | -0.44% |
| 2020 Q2 | 36.74 Million USD | -11.76% |
| 2020 Q4 | 72.34 Million USD | 5.81% |
| 2019 Q3 | 37.61 Million USD | 23.36% |
| 2019 FY | 41.82 Million USD | 189.64% |
| 2019 Q4 | 41.82 Million USD | 11.19% |
| 2019 Q2 | 30.49 Million USD | 14.96% |
| 2019 Q1 | 26.52 Million USD | 83.69% |
| 2018 Q3 | 15.38 Million USD | 4.53% |
| 2018 Q4 | 14.44 Million USD | -6.12% |
| 2018 Q2 | 14.71 Million USD | -4.15% |
| 2018 Q1 | 15.35 Million USD | -18.5% |
| 2018 FY | 14.44 Million USD | -23.34% |
| 2017 FY | 18.83 Million USD | 13.2% |
| 2017 Q4 | 18.83 Million USD | 19.39% |
| 2017 Q2 | 16.28 Million USD | -4.92% |
| 2017 Q3 | 15.77 Million USD | -3.13% |
| 2017 Q1 | 17.13 Million USD | 2.94% |
| 2016 Q1 | 3.91 Million USD | 48.7% |
| 2016 FY | 16.64 Million USD | 532.29% |
| 2016 Q4 | 16.64 Million USD | 147.07% |
| 2016 Q2 | 5.1 Million USD | 30.4% |
| 2016 Q3 | 6.73 Million USD | 31.98% |
| 2015 Q3 | 2.23 Million USD | -84.14% |
| 2015 Q1 | - USD | -100.0% |
| 2015 Q4 | 2.63 Million USD | 17.81% |
| 2015 Q2 | 14.08 Million USD | 0.0% |
| 2015 FY | 2.63 Million USD | -56.05% |
| 2014 FY | 5.98 Million USD | 45.18% |
| 2014 Q1 | - USD | 0.0% |
| 2014 Q4 | 5.98 Million USD | 0.0% |
| 2013 FY | 4.12 Million USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Akebia Therapeutics, Inc. | 272.28 Million USD | -45.897% |
| Jaguar Health, Inc. | 45.86 Million USD | -766.13% |
| Keros Therapeutics, Inc. | 37.81 Million USD | -950.616% |
| Longboard Pharmaceuticals, Inc. | 9.77 Million USD | -3964.446% |
| Alnylam Pharmaceuticals, Inc. | 4.05 Billion USD | 90.192% |
| Ligand Pharmaceuticals Incorporated | 130.7 Million USD | -203.931% |
| ContextLogic Inc. | 206 Million USD | -92.844% |
| MiMedx Group, Inc. | 96.33 Million USD | -312.394% |
| MEI Pharma, Inc. | 8.35 Million USD | -4654.746% |
| AlloVir, Inc. | 45.01 Million USD | -782.504% |
| Novavax, Inc. | 2.57 Billion USD | 84.556% |
| Aptorum Group Limited | 5.25 Million USD | -7457.139% |
| Ardelyx, Inc. | 130.76 Million USD | -203.801% |
| Arrowhead Pharmaceuticals, Inc. | 478.39 Million USD | 16.959% |
| Psyence Biomedical Ltd. | 12.1 Million USD | -3181.858% |
| Vaxcyte, Inc. | 167.44 Million USD | -137.242% |
| Precigen, Inc. | 41.64 Million USD | -853.941% |
| Pharming Group N.V. | 244.07 Million USD | -62.762% |
| Phathom Pharmaceuticals, Inc. | 486.6 Million USD | 18.36% |
| Pieris Pharmaceuticals, Inc. | 11.92 Million USD | -3232.151% |
| Rigel Pharmaceuticals, Inc. | 145.86 Million USD | -172.34% |
| Avidity Biosciences, Inc. | 127.79 Million USD | -210.866% |
| TransCode Therapeutics, Inc. | 3.52 Million USD | -11157.345% |
| Reviva Pharmaceuticals Holdings, Inc. | 6.6 Million USD | -5912.445% |
| Reviva Pharmaceuticals Holdings, Inc. | 6.6 Million USD | -5912.445% |
| Bicycle Therapeutics plc | 224.41 Million USD | -77.022% |
| Sangamo Therapeutics, Inc. | 82.43 Million USD | -381.917% |
| Sol-Gel Technologies Ltd. | 6.64 Million USD | -5880.114% |
| Acelyrin, Inc. | 86.35 Million USD | -360.041% |
| SELLAS Life Sciences Group, Inc. | 14.37 Million USD | -2662.772% |
| Sensei Biotherapeutics, Inc. | 9.47 Million USD | -4090.938% |
| Senti Biosciences, Inc. | 52.57 Million USD | -655.662% |
| Stoke Therapeutics, Inc. | 68.77 Million USD | -477.604% |
| AbCellera Biologics Inc. | 335.77 Million USD | -18.311% |
| Alaunos Therapeutics, Inc. | 1.95 Million USD | -20209.765% |
| BioXcel Therapeutics, Inc. | 130.21 Million USD | -205.091% |
| Entrada Therapeutics, Inc. | 226.83 Million USD | -75.134% |
| Chimerix, Inc. | 19.74 Million USD | -1911.947% |
| VistaGen Therapeutics, Inc. | 9.36 Million USD | -4141.048% |
| Windtree Therapeutics, Inc. | 29.01 Million USD | -1269.15% |
| Corbus Pharmaceuticals Holdings, Inc. | 35.17 Million USD | -1029.311% |
| Viracta Therapeutics, Inc. | 38.37 Million USD | -935.257% |
| Elevation Oncology, Inc. | 34.28 Million USD | -1058.798% |
| Alkermes plc | 933.53 Million USD | 57.446% |
| Fortress Biotech, Inc. | 165.93 Million USD | -139.401% |
| Fortress Biotech, Inc. | 165.93 Million USD | -139.401% |
| Agenus Inc. | 462.29 Million USD | 14.068% |
| HOOKIPA Pharma Inc. | 71.48 Million USD | -455.762% |
| Dyadic International, Inc. | 2.34 Million USD | -16872.159% |
| ImmuCell Corporation | 18.81 Million USD | -2011.392% |
| Eton Pharmaceuticals, Inc. | 16.26 Million USD | -2342.717% |
| IDEAYA Biosciences, Inc. | 28.22 Million USD | -1307.422% |
| Lantern Pharma Inc. | 2.73 Million USD | -14400.187% |
| Immix Biopharma, Inc. | 3.72 Million USD | -10573.889% |
| Incyte Corporation | 1.59 Billion USD | 75.051% |
| IO Biotech, Inc. | 17.55 Million USD | -2162.81% |
| Janux Therapeutics, Inc. | 36.05 Million USD | -1001.722% |
| Inhibikase Therapeutics, Inc. | 3.52 Million USD | -11157.862% |
| Outlook Therapeutics, Inc. | 46.73 Million USD | -749.952% |
| Syros Pharmaceuticals, Inc. | 151.51 Million USD | -162.196% |
| Kintara Therapeutics, Inc. | 2.44 Million USD | -16147.812% |
| Barinthus Biotherapeutics plc | 27.51 Million USD | -1344.001% |
| Madrigal Pharmaceuticals, Inc. | 235.21 Million USD | -68.893% |
| Sorrento Therapeutics, Inc. | 494.5 Million USD | 19.666% |
| NextCure, Inc. | 14.99 Million USD | -2548.923% |
| Ocuphire Pharma, Inc. | 4.04 Million USD | -9728.278% |
| Onconetix, Inc. | 23.18 Million USD | -1613.735% |
| Oncternal Therapeutics, Inc. | 6.67 Million USD | -5849.663% |
| Opthea Limited | 264.6 Million USD | -50.135% |
| PDS Biotechnology Corporation | 33.25 Million USD | -1094.436% |
| PureTech Health plc | 125.58 Million USD | -216.332% |
| Pyxis Oncology, Inc. | 48.02 Million USD | -727.244% |
| Seer, Inc. | 39.36 Million USD | -909.168% |
| Salarius Pharmaceuticals, Inc. | 1.29 Million USD | -30476.236% |
| Clearside Biomedical, Inc. | 49.93 Million USD | -695.632% |
| Telomir Pharmaceuticals, Inc. Common Stock | 1.33 Million USD | -29644.662% |
| VYNE Therapeutics Inc. | 8.95 Million USD | -4338.648% |
| Wave Life Sciences Ltd. | 227.44 Million USD | -74.662% |
| Xeris Biopharma Holdings, Inc. | 347.58 Million USD | -14.293% |
| C4 Therapeutics, Inc. | 130.33 Million USD | -204.794% |
| ChromaDex Corporation | 26.5 Million USD | -1398.638% |
| TRACON Pharmaceuticals, Inc. | 10.91 Million USD | -3539.903% |
| Caribou Biosciences, Inc. | 72.56 Million USD | -447.438% |
| CRISPR Therapeutics AG | 346.76 Million USD | -14.56% |
| Precision BioSciences, Inc. | 140.92 Million USD | -181.904% |
| Fate Therapeutics, Inc. | 137.8 Million USD | -188.287% |
| Innoviva, Inc. | 568.55 Million USD | 30.128% |
| Summit Therapeutics Inc. | 125.25 Million USD | -217.155% |
| Verrica Pharmaceuticals Inc. | 61.83 Million USD | -542.46% |
| Aadi Bioscience, Inc. | 27.22 Million USD | -1359.009% |
| ESSA Pharma Inc. | 3.49 Million USD | -11266.264% |
| GlycoMimetics, Inc. | 6.9 Million USD | -5655.647% |
| GT Biopharma, Inc. | 6.63 Million USD | -5889.13% |
| Inhibrx Biosciences, Inc. | 264.39 Million USD | -50.255% |
| Catalyst Pharmaceuticals, Inc. | 84.02 Million USD | -372.781% |
| Orchestra BioMed Holdings, Inc. | 27.16 Million USD | -1362.177% |
| Alzamend Neuro, Inc. | 3.22 Million USD | -12215.157% |
| Rocket Pharmaceuticals, Inc. | 73.76 Million USD | -438.532% |
| Aptose Biosciences Inc. | 15.8 Million USD | -2412.914% |
| ZyVersa Therapeutics, Inc. | 11.03 Million USD | -3498.463% |
| Soligenix, Inc. | 7.27 Million USD | -5360.677% |
| Century Therapeutics, Inc. | 175.94 Million USD | -125.791% |
| Kura Oncology, Inc. | 51.66 Million USD | -668.958% |
| TScan Therapeutics, Inc. | 121.28 Million USD | -227.55% |
| Intensity Therapeutics, Inc. | 4.13 Million USD | -9511.88% |
| Ocean Biomedical, Inc. | 6.61 Million USD | -5906.467% |
| CytomX Therapeutics, Inc. | 252.59 Million USD | -57.269% |
| Autolus Therapeutics plc | 263.9 Million USD | -50.53% |
| Mineralys Therapeutics, Inc. | 10.48 Million USD | -3689.916% |
| EyePoint Pharmaceuticals, Inc. | 88.86 Million USD | -347.057% |
| Eterna Therapeutics Inc. | 46.89 Million USD | -747.052% |
| Adaptive Biotechnologies Corporation | 352.85 Million USD | -12.584% |
| GRI Bio, Inc. | 2.69 Million USD | -14629.663% |
| Xenetic Biosciences, Inc. | 809.58 Thousand USD | -48969.462% |
| Tenaya Therapeutics, Inc. | 31.09 Million USD | -1177.73% |
| IGM Biosciences, Inc. | 220.17 Million USD | -80.427% |
| INmune Bio, Inc. | 18.86 Million USD | -2006.134% |
| Heron Therapeutics, Inc. | 256.47 Million USD | -54.889% |
| SAB Biotherapeutics, Inc. | 26.64 Million USD | -1391.111% |
| Pasithea Therapeutics Corp. | 2.71 Million USD | -14513.674% |
| Entero Therapeutics, Inc. | 3.28 Million USD | -12010.573% |
| Milestone Pharmaceuticals Inc. | 58.45 Million USD | -579.598% |
| X4 Pharmaceuticals, Inc. | 96.15 Million USD | -313.127% |
| Atara Biotherapeutics, Inc. | 264.73 Million USD | -50.059% |
| Coherus BioSciences, Inc. | 823.02 Million USD | 51.732% |
| Verastem, Inc. | 71.18 Million USD | -458.066% |
| Abeona Therapeutics Inc. | 49.17 Million USD | -707.831% |
| Pliant Therapeutics, Inc. | 38.57 Million USD | -929.755% |
| Tonix Pharmaceuticals Holding Corp. | 48.93 Million USD | -711.859% |
| Histogen Inc. | 5.69 Million USD | -6873.126% |
| Aprea Therapeutics, Inc. | 4.38 Million USD | -8958.249% |
| Surrozen, Inc. | 8.14 Million USD | -4777.336% |
| Organovo Holdings, Inc. | 2.74 Million USD | -14356.295% |
| Lixte Biotechnology Holdings, Inc. | 313.85 Thousand USD | -126472.845% |
| Ovid Therapeutics Inc. | 56.22 Million USD | -606.491% |
| Panbela Therapeutics, Inc. | 16.51 Million USD | -2305.881% |
| CASI Pharmaceuticals, Inc. | 51.1 Million USD | -677.369% |
| Cadrenal Therapeutics, Inc. Common Stock | 826.87 Thousand USD | -47943.416% |
| Centessa Pharmaceuticals plc | 126.72 Million USD | -213.481% |
| Hepion Pharmaceuticals, Inc. | 10.81 Million USD | -3573.701% |
| Arcturus Therapeutics Holdings Inc. | 150.88 Million USD | -163.279% |
| BioRestorative Therapies, Inc. | 2.6 Million USD | -15136.15% |
| Apollomics, Inc. | 14.15 Million USD | -2706.889% |
| Amarin Corporation plc | 279.58 Million USD | -42.088% |
| Mesoblast Limited | 188.79 Million USD | -110.415% |
| Turnstone Biologics Corp. | 14.14 Million USD | -2707.881% |
| Kymera Therapeutics, Inc. | 180.78 Million USD | -119.737% |
| Synaptogenix, Inc. | 5.52 Million USD | -7084.397% |
| Tiziana Life Sciences Ltd | 6.64 Million USD | -5875.617% |
| Aurinia Pharmaceuticals Inc. | 170.1 Million USD | -133.533% |
| BriaCell Therapeutics Corp. | 8.55 Million USD | -4542.399% |
| Monopar Therapeutics Inc. | 1.75 Million USD | -22505.018% |
| Exelixis, Inc. | 678.44 Million USD | 41.446% |
| Better Therapeutics, Inc. | 23.84 Million USD | -1566.215% |
| Nurix Therapeutics, Inc. | 164.04 Million USD | -142.163% |
| Apellis Pharmaceuticals, Inc. | 594.2 Million USD | 33.145% |
| NLS Pharmaceutics AG | 10.68 Million USD | -3619.583% |
| Dermata Therapeutics, Inc. | 1.62 Million USD | -24367.547% |
| Aridis Pharmaceuticals, Inc. | 38.92 Million USD | -920.523% |
| Gritstone bio, Inc. | 125.91 Million USD | -215.488% |
| Jasper Therapeutics, Inc. | 14.67 Million USD | -2606.862% |
| TNF Pharmaceuticals, Inc. | 5.08 Million USD | -7706.801% |
| Avid Bioservices, Inc. | 275.66 Million USD | -44.108% |
| Insmed Incorporated | 1.66 Billion USD | 76.094% |
| Virpax Pharmaceuticals, Inc. | 7.69 Million USD | -5063.215% |
| MediWound Ltd. | 27.18 Million USD | -1361.209% |
| OmniAb, Inc. | 87.4 Million USD | -354.53% |
| Alector, Inc. | 487.66 Million USD | 18.539% |
| Seres Therapeutics, Inc. | 403.45 Million USD | 1.536% |
| Checkpoint Therapeutics, Inc. | 18.42 Million USD | -2056.087% |
| Zai Lab Limited | 240.17 Million USD | -65.403% |
| Revance Therapeutics, Inc. | 630.05 Million USD | 36.949% |
| Aura Biosciences, Inc. | 29.22 Million USD | -1259.219% |
| Lyell Immunopharma, Inc. | 95.07 Million USD | -317.829% |
| Immunic, Inc. | 25.36 Million USD | -1465.985% |
| Tarsus Pharmaceuticals, Inc. | 69.23 Million USD | -473.775% |
| Veracyte, Inc. | 93.71 Million USD | -323.883% |
| InMed Pharmaceuticals Inc. | 2.61 Million USD | -15081.836% |
| FibroGen, Inc. | 585.72 Million USD | 32.177% |
| SeaStar Medical Holding Corporation | 17.38 Million USD | -2185.33% |
| Adial Pharmaceuticals, Inc. | 653.07 Thousand USD | -60728.908% |
| Sonnet BioTherapeutics Holdings, Inc. | 5.65 Million USD | -6924.347% |
| Jazz Pharmaceuticals plc | 7.65 Billion USD | 94.811% |
| Cyclacel Pharmaceuticals, Inc. | 8.19 Million USD | -4745.804% |
| Amylyx Pharmaceuticals, Inc. | 84.02 Million USD | -372.804% |
| TG Therapeutics, Inc. | 169.08 Million USD | -134.946% |
| Galecto, Inc. | 5.89 Million USD | -6637.771% |
| Calithera Biosciences, Inc. | 8.28 Million USD | -4695.497% |
| Fortrea Holdings Inc. | 2.61 Billion USD | 84.828% |
| KalVista Pharmaceuticals, Inc. | 28.82 Million USD | -1278.319% |
| Aptevo Therapeutics Inc. | 12.62 Million USD | -3047.603% |
| XBiotech Inc. | 8.39 Million USD | -4630.963% |
| Jasper Therapeutics, Inc. | 14.67 Million USD | -2606.862% |
| Lyra Therapeutics, Inc. | 53.18 Million USD | -647.008% |
| Foghorn Therapeutics Inc. | 363.1 Million USD | -9.406% |
| Y-mAbs Therapeutics, Inc. | 26.88 Million USD | -1377.678% |
| Theravance Biopharma, Inc. | 169 Million USD | -135.059% |
| Ultragenyx Pharmaceutical Inc. | 1.21 Billion USD | 67.32% |
| Metagenomi, Inc. Common Stock | 500.42 Million USD | 20.616% |
| Vaxxinity, Inc. | 30.94 Million USD | -1183.8% |
| BioCryst Pharmaceuticals, Inc. | 972.48 Million USD | 59.15% |
| Gain Therapeutics, Inc. | 6.03 Million USD | -6486.834% |
| Cartesian Therapeutics, Inc. | 745.23 Million USD | 46.693% |
| NexImmune, Inc. | 5.08 Million USD | -7713.55% |
| Creative Medical Technology Holdings, Inc. | 371.39 Thousand USD | -106864.302% |
| Marker Therapeutics, Inc. | 3.07 Million USD | -12819.63% |
| Regeneron Pharmaceuticals, Inc. | 7.1 Billion USD | 94.41% |
| Chemomab Therapeutics Ltd. | 5.15 Million USD | -7607.736% |
| Scopus BioPharma Inc. | 7.45 Million USD | -5229.164% |
| RAPT Therapeutics, Inc. | 26.29 Million USD | -1410.835% |
| Ainos, Inc. | 7.39 Million USD | -5272.559% |
| Pluri Inc. | 34.11 Million USD | -1064.573% |
| Prothena Corporation plc | 135.01 Million USD | -194.229% |
| Adaptimmune Therapeutics plc | 243.1 Million USD | -63.412% |
| Celularity Inc. | 102.92 Million USD | -285.954% |
| Rallybio Corporation | 9.43 Million USD | -4110.036% |
| Cue Biopharma, Inc. | 24.44 Million USD | -1525.114% |
| MeiraGTx Holdings plc | 319.99 Million USD | -24.147% |
| Omeros Corporation | 403.25 Million USD | 1.486% |
| Humacyte, Inc. | 114.67 Million USD | -246.416% |
| Immunocore Holdings plc | 228.15 Million USD | -74.116% |
| Cocrystal Pharma, Inc. | 4.87 Million USD | -8048.903% |
| Cidara Therapeutics, Inc. | 76.74 Million USD | -417.669% |
| Blueprint Medicines Corporation | 918.64 Million USD | 56.756% |
| CalciMedica, Inc. | 4.02 Million USD | -9762.438% |
| Cabaletta Bio, Inc. | 17.45 Million USD | -2176.295% |
| Marinus Pharmaceuticals, Inc. | 154.14 Million USD | -157.721% |
| Scholar Rock Holding Corporation | 85.81 Million USD | -362.914% |
| Sana Biotechnology, Inc. | 277.79 Million USD | -43.005% |
| Pulmatrix, Inc. | 15.96 Million USD | -2388.624% |
| Elicio Therapeutics, Inc. | 15.77 Million USD | -2418.601% |
| Vigil Neuroscience, Inc. | 24.6 Million USD | -1514.48% |
| Intellia Therapeutics, Inc. | 250.8 Million USD | -58.392% |
| Adlai Nortye Ltd. American Depositary Shares | 50.78 Million USD | -682.221% |
| Cytokinetics, Incorporated | 1.21 Billion USD | 67.186% |
| Eloxx Pharmaceuticals, Inc. | 31.78 Million USD | -1149.91% |
| Nutriband Inc. | 1.07 Million USD | -36720.095% |
| Protara Therapeutics, Inc. | 10.63 Million USD | -3636.095% |
| Vor Biopharma Inc. | 59.1 Million USD | -572.136% |
| Roivant Sciences Ltd. | 773.95 Million USD | 48.671% |
| Evogene Ltd. | 17.99 Million USD | -2108.221% |
| ProKidney Corp. | 29.21 Million USD | -1259.731% |
| Applied Therapeutics, Inc. | 71.97 Million USD | -451.91% |
| Hoth Therapeutics, Inc. | 704.98 Thousand USD | -56250.153% |
| BridgeBio Pharma, Inc. | 1.88 Billion USD | 78.969% |
| CorMedix Inc. | 11.91 Million USD | -3233.401% |
| BioLineRx Ltd. | 50.7 Million USD | -683.517% |
| Tango Therapeutics, Inc. | 149.45 Million USD | -165.798% |
| Galectin Therapeutics Inc. | 88.44 Million USD | -349.18% |
| Atai Life Sciences N.V. | 49.16 Million USD | -708.061% |
| Renovaro Biosciences Inc. | 31.15 Million USD | -1175.215% |
| Aerovate Therapeutics, Inc. | 17.96 Million USD | -2111.664% |
| Zentalis Pharmaceuticals, Inc. | 124.63 Million USD | -218.735% |
| Sagimet Biosciences Inc. | 5.65 Million USD | -6926.158% |
| MediciNova, Inc. | 3.89 Million USD | -10108.238% |
| Praxis Precision Medicines, Inc. | 18.27 Million USD | -2073.308% |
| Cardio Diagnostics Holdings, Inc. | 1.5 Million USD | -26309.266% |
| GeoVax Labs, Inc. | 3.51 Million USD | -11186.149% |
| Biomea Fusion, Inc. | 30.69 Million USD | -1194.425% |
| PTC Therapeutics, Inc. | 2.72 Billion USD | 85.404% |
| Mereo BioPharma Group plc | 15.96 Million USD | -2388.78% |
| Cullinan Oncology, Inc. | 31.2 Million USD | -1173.225% |
| Syndax Pharmaceuticals, Inc. | 58.68 Million USD | -576.946% |
| Absci Corporation | 58.3 Million USD | -581.358% |
| NRx Pharmaceuticals, Inc. | 19.04 Million USD | -1985.568% |
| 4D Molecular Therapeutics, Inc. | 32.06 Million USD | -1139.034% |
| Dyne Therapeutics, Inc. | 73.79 Million USD | -438.364% |
| Kiniksa Pharmaceuticals, Ltd. | 87.48 Million USD | -354.099% |
| Ventyx Biosciences, Inc. | 33.77 Million USD | -1076.367% |
| Allakos Inc. | 74.79 Million USD | -431.145% |
| Imunon, Inc. | 8.53 Million USD | -4556.965% |
| Fulcrum Therapeutics, Inc. | 22.5 Million USD | -1665.517% |
| Corcept Therapeutics Incorporated | 114.81 Million USD | -246.008% |
| BioAtla, Inc. | 48.98 Million USD | -710.964% |
| NLS Pharmaceutics AG | 10.68 Million USD | -3619.583% |
| Bio-Path Holdings, Inc. | 2.77 Million USD | -14195.034% |
| Allogene Therapeutics, Inc. | 130.6 Million USD | -204.171% |
| Larimar Therapeutics, Inc. | 14.21 Million USD | -2694.647% |
| XOMA Corporation | 145.58 Million USD | -172.88% |
| Kezar Life Sciences, Inc. | 33.66 Million USD | -1080.036% |
| Cara Therapeutics, Inc. | 68.75 Million USD | -477.756% |
| aTyr Pharma, Inc. | 31.59 Million USD | -1157.268% |
| Aligos Therapeutics, Inc. | 61.82 Million USD | -542.575% |
| Akero Therapeutics, Inc. | 44.96 Million USD | -783.485% |
| Viridian Therapeutics, Inc. | 48.4 Million USD | -720.749% |
| Eliem Therapeutics, Inc. | 2.87 Million USD | -13741.777% |
| EyeGate Pharmaceuticals, Inc. | 8.15 Million USD | -4769.553% |
| Akari Therapeutics, Plc | 4.58 Million USD | -8566.209% |
| Tevogen Bio Holdings Inc. | 17.73 Million USD | -2140.208% |
| Halozyme Therapeutics, Inc. | 1.64 Billion USD | 75.916% |
| Lexaria Bioscience Corp. | 403.9 Thousand USD | -98253.833% |
| UroGen Pharma Ltd. | 243.52 Million USD | -63.13% |
| Sutro Biopharma, Inc. | 321.08 Million USD | -23.723% |
| ZIVO Bioscience, Inc. | 2.76 Million USD | -14285.322% |
| Orgenesis Inc. | 35.53 Million USD | -1017.937% |
| Entera Bio Ltd. | 1.37 Million USD | -28707.759% |
| GH Research PLC | 6.7 Million USD | -5828.354% |
| Lisata Therapeutics, Inc. | 6.8 Million USD | -5742.044% |
| Reneo Pharmaceuticals, Inc. | 18.82 Million USD | -2010.161% |
| Xencor, Inc. | 283.55 Million USD | -40.097% |
| 60 Degrees Pharmaceuticals, Inc. | 2.98 Million USD | -13205.5% |
| Replimune Group, Inc. | 113.21 Million USD | -250.892% |
| Coeptis Therapeutics Holdings, Inc. | 3.75 Million USD | -10473.484% |
| Vanda Pharmaceuticals Inc. | 103.53 Million USD | -283.714% |
| Lexaria Bioscience Corp. | 403.9 Thousand USD | -98253.833% |
| Portage Biotech Inc. | 4.45 Million USD | -8827.169% |
| Cardio Diagnostics Holdings, Inc. | 1.5 Million USD | -26309.266% |
| Olema Pharmaceuticals, Inc. | 23.05 Million USD | -1623.466% |
| OncoCyte Corporation | 49.29 Million USD | -705.832% |
| Qualigen Therapeutics, Inc. | 4.13 Million USD | -9503.039% |
| Processa Pharmaceuticals, Inc. | 797.48 Thousand USD | -49714.04% |
| Purple Biotech Ltd. | 10 Million USD | -3870.605% |
| CollPlant Biotechnologies Ltd. | 5.78 Million USD | -6765.866% |
| scPharmaceuticals Inc. | 57.26 Million USD | -593.769% |
| ProMIS Neurosciences, Inc. | 12.38 Million USD | -3106.8% |
| HilleVax, Inc. | 78.9 Million USD | -403.439% |
| NeuroSense Therapeutics Ltd. | 5.05 Million USD | -7766.515% |
| Tharimmune, Inc. | 1.81 Million USD | -21786.993% |
| Genprex, Inc. | 3.25 Million USD | -12107.548% |
| Neumora Therapeutics, Inc. Common Stock | 27.11 Million USD | -1364.873% |
| Atossa Therapeutics, Inc. | 5.23 Million USD | -7487.07% |
| XTL Biopharmaceuticals Ltd. | 206 Thousand USD | -192744.175% |
| Virios Therapeutics, Inc. | 358.54 Thousand USD | -110696.602% |
| OKYO Pharma Limited | 7.42 Million USD | -5253.285% |
| Savara Inc. | 37.19 Million USD | -968.13% |
| Curis, Inc. | 57.61 Million USD | -589.542% |
| Daré Bioscience, Inc. | 26.32 Million USD | -1408.778% |
| Carmell Therapeutics Corporation | 39.19 Million USD | -913.421% |
| Titan Pharmaceuticals, Inc. | 1.44 Million USD | -27411.011% |
| Achieve Life Sciences, Inc. | 20.81 Million USD | -1808.156% |
| BeiGene, Ltd. | 2.23 Billion USD | 82.216% |
| Kiromic BioPharma, Inc. | 21.28 Million USD | -1765.959% |
| Revolution Medicines, Inc. Warrant | 262.39 Million USD | -51.396% |
| Protagonist Therapeutics, Inc. | 21.27 Million USD | -1767.345% |
| Erasca, Inc. | 78.61 Million USD | -405.348% |
| bluebird bio, Inc. | 424.62 Million USD | 6.445% |
| Protagenic Therapeutics, Inc. | 655.25 Thousand USD | -60526.904% |
| BioMarin Pharmaceutical Inc. | 1.89 Billion USD | 78.982% |
| DBV Technologies S.A. | 42.8 Million USD | -828.175% |
| Protagenic Therapeutics, Inc. | 655.25 Thousand USD | -60526.904% |
| Moderna, Inc. | 4.57 Billion USD | 91.311% |
| Vincerx Pharma, Inc. | 6.99 Million USD | -5579.185% |
| Fresh Tracks Therapeutics, Inc. | 1.65 Million USD | -23889.07% |
| Molecular Templates, Inc. | 31.17 Million USD | -1174.451% |
| Acrivon Therapeutics, Inc. Common Stock | 17.07 Million USD | -2227.235% |
| Travere Therapeutics, Inc. | 588.1 Million USD | 32.451% |
| Monte Rosa Therapeutics, Inc. | 124.5 Million USD | -219.071% |
| Spruce Biosciences, Inc. | 27.43 Million USD | -1347.895% |
| Celldex Therapeutics, Inc. | 36.45 Million USD | -989.694% |
| Cogent Biosciences, Inc. | 55.63 Million USD | -614.045% |
| MacroGenics, Inc. | 154.2 Million USD | -157.614% |
| RenovoRx, Inc. | 4.46 Million USD | -8795.186% |
| Adicet Bio, Inc. | 37.12 Million USD | -970.202% |
| Prime Medicine, Inc. | 60.78 Million USD | -553.602% |
| Aditxt, Inc. | 28.53 Million USD | -1292.349% |
| Adagene Inc. | 45.16 Million USD | -779.488% |
| Estrella Immunopharma, Inc. | 180.7 Thousand USD | -219743.277% |
| Quantum-Si incorporated | 26.63 Million USD | -1391.716% |
| Maravai LifeSciences Holdings, Inc. | 697.56 Million USD | 43.051% |
| Acurx Pharmaceuticals, Inc. | 3.04 Million USD | -12957.259% |
| Voyager Therapeutics, Inc. | 114.96 Million USD | -245.56% |
| SciSparc Ltd. | 1.59 Million USD | -24806.52% |
| Vericel Corporation | 127.7 Million USD | -211.076% |
| Revelation Biosciences, Inc. | 5.56 Million USD | -7038.662% |
| Minerva Neurosciences, Inc. | 85.35 Million USD | -365.403% |
| Generation Bio Co. | 171.63 Million USD | -131.462% |
| Astria Therapeutics, Inc. | 11.55 Million USD | -3339.472% |
| Black Diamond Therapeutics, Inc. | 41.83 Million USD | -849.676% |
| Arcutis Biotherapeutics, Inc. | 252.69 Million USD | -57.207% |
| Invivyd, Inc. | 51.71 Million USD | -668.199% |
| Relay Therapeutics, Inc. | 91.97 Million USD | -331.911% |
| Quoin Pharmaceuticals, Ltd. | 6.5 Million USD | -6006.744% |
| Spero Therapeutics, Inc. | 75.49 Million USD | -426.199% |
| Artelo Biosciences, Inc. | 1.02 Million USD | -38808.815% |
| 2seventy bio, Inc. | 310.12 Million USD | -28.096% |
| ADMA Biologics, Inc. | 193.97 Million USD | -104.798% |
| Clene Inc. | 38.95 Million USD | -919.894% |
| Capricor Therapeutics, Inc. | 36.13 Million USD | -999.44% |
| Boundless Bio, Inc. Common Stock | 256.97 Million USD | -54.59% |
| GeoVax Labs, Inc. | 3.51 Million USD | -11186.149% |
| Recursion Pharmaceuticals, Inc. | 190.26 Million USD | -108.795% |
| Citius Pharmaceuticals, Inc. | 12.17 Million USD | -3161.659% |
| Contineum Therapeutics, Inc. Class A Common Stock | 198.32 Million USD | -100.31% |
| Relmada Therapeutics, Inc. | 12.19 Million USD | -3157.61% |
| Finch Therapeutics Group, Inc. | 48.11 Million USD | -725.713% |
| ALX Oncology Holdings Inc. | 52.84 Million USD | -651.801% |
| Vir Biotechnology, Inc. | 369.85 Million USD | -7.41% |
| Evaxion Biotech A/S | 17.61 Million USD | -2154.914% |
| Ocular Therapeutix, Inc. | 160.92 Million USD | -146.854% |
| Verve Therapeutics, Inc. | 153.18 Million USD | -159.331% |
| Trevena, Inc. | 48.26 Million USD | -723.13% |
| Surrozen, Inc. | 8.14 Million USD | -4777.336% |
| Tyra Biosciences, Inc. | 21.59 Million USD | -1739.588% |
| Cingulate Inc. | 10.36 Million USD | -3734.226% |
| Galmed Pharmaceuticals Ltd. | 2.75 Million USD | -14345.782% |
| Unity Biotechnology, Inc. | 37.29 Million USD | -965.266% |
| Tenax Therapeutics, Inc. | 3.58 Million USD | -10976.447% |
| Terns Pharmaceuticals, Inc. | 13.15 Million USD | -2920.981% |
| ACADIA Pharmaceuticals Inc. | 317.2 Million USD | -25.239% |
| Connect Biopharma Holdings Limited | 24.84 Million USD | -1498.692% |
| Clearmind Medicine Inc. | 3.61 Million USD | -10904.38% |
| Kronos Bio, Inc. | 54.2 Million USD | -632.937% |
| Bolt Biotherapeutics, Inc. | 47.04 Million USD | -744.459% |
| CERo Therapeutics Holdings, Inc. | 22.75 Million USD | -1645.447% |
| Viking Therapeutics, Inc. | 20.07 Million USD | -1879.269% |
| Statera Biopharma, Inc. | 22.67 Million USD | -1651.857% |
| ImmunityBio, Inc. | 1.09 Billion USD | 63.567% |
| Korro Bio, Inc. | 51.75 Million USD | -667.621% |
| Kineta, Inc. | 7.22 Million USD | -5400.678% |
| BioVie Inc. | 9.7 Million USD | -3994.554% |
| Codexis, Inc. | 49.94 Million USD | -695.377% |
| Celularity Inc. | 102.92 Million USD | -285.954% |
| Crinetics Pharmaceuticals, Inc. | 96.24 Million USD | -312.749% |
| Celcuity Inc. | 51.45 Million USD | -672.125% |
| Virax Biolabs Group Limited | 345.19 Thousand USD | -114982.823% |
| Cibus, Inc. | 206.11 Million USD | -92.735% |
| Eledon Pharmaceuticals, Inc. | 42.47 Million USD | -835.277% |
| eFFECTOR Therapeutics, Inc. | 26.33 Million USD | -1408.254% |
| IN8bio, Inc. | 8.77 Million USD | -4428.716% |
| Kodiak Sciences Inc. | 213.59 Million USD | -85.991% |
| Annexon, Inc. | 47.11 Million USD | -743.115% |
| Adverum Biotechnologies, Inc. | 89.54 Million USD | -343.662% |
| Assembly Biosciences, Inc. | 96.37 Million USD | -312.214% |
| Avalo Therapeutics, Inc. | 13.68 Million USD | -2802.031% |
| Ionis Pharmaceuticals, Inc. | 2.6 Billion USD | 84.741% |
| Eyenovia, Inc. | 19.78 Million USD | -1908.359% |
| Puma Biotechnology, Inc. | 177.08 Million USD | -124.331% |
| Conduit Pharmaceuticals Inc. | 7.68 Million USD | -5071.97% |
| Xilio Therapeutics, Inc. | 24.09 Million USD | -1548.446% |
| Arcellx, Inc. | 339.75 Million USD | -16.926% |
| Cardiff Oncology, Inc. | 11.89 Million USD | -3238.872% |
| Enanta Pharmaceuticals, Inc. | 245.54 Million USD | -61.79% |
| Regulus Therapeutics Inc. | 9.56 Million USD | -4054.125% |
| Moolec Science SA | 13.94 Million USD | -2748.683% |
| Acumen Pharmaceuticals, Inc. | 43.15 Million USD | -820.604% |
| Geron Corporation | 146.12 Million USD | -171.859% |
| LAVA Therapeutics N.V. | 50.53 Million USD | -686.153% |
| Royalty Pharma plc | 6.29 Billion USD | 93.692% |
| Atea Pharmaceuticals, Inc. | 39.77 Million USD | -898.74% |
| Greenwich LifeSciences, Inc. | 294.4 Thousand USD | -134835.769% |
| TFF Pharmaceuticals, Inc. | 2.46 Million USD | -16046.889% |
| Mersana Therapeutics, Inc. | 189.15 Million USD | -110.017% |
| Humacyte, Inc. | 114.67 Million USD | -246.416% |
| Structure Therapeutics Inc. | 29.05 Million USD | -1267.454% |
| 89bio, Inc. | 59.96 Million USD | -562.507% |
| PMV Pharmaceuticals, Inc. | 26.46 Million USD | -1401.187% |
| Avenue Therapeutics, Inc. | 1.19 Million USD | -33115.635% |
| Genelux Corporation | 8.42 Million USD | -4618.04% |
| Trevi Therapeutics, Inc. | 6.85 Million USD | -5694.326% |
| Lexicon Pharmaceuticals, Inc. | 136.31 Million USD | -191.419% |
| Notable Labs, Ltd. | 4.42 Million USD | -8873.549% |
| Liquidia Corporation | 73.13 Million USD | -443.164% |
| Mustang Bio, Inc. | 17.61 Million USD | -2154.719% |
| Immunovant, Inc. | 48.95 Million USD | -711.478% |
| Quantum-Si incorporated | 26.63 Million USD | -1391.716% |
| Arbutus Biopharma Corporation | 38.38 Million USD | -934.987% |
| DiaMedica Therapeutics Inc. | 3.1 Million USD | -12702.417% |
| Vera Therapeutics, Inc. | 73.86 Million USD | -437.847% |
| Acasti Pharma Inc. | 11.55 Million USD | -3337.389% |
| MiNK Therapeutics, Inc. | 22.6 Million USD | -1657.182% |
| Pasithea Therapeutics Corp. | 2.71 Million USD | -14513.674% |
| Xenon Pharmaceuticals Inc. | 36.87 Million USD | -977.254% |
| Elevai Labs, Inc. Common Stock | 1.36 Million USD | -29049.307% |
| NeuroBo Pharmaceuticals, Inc. | 6.09 Million USD | -6416.716% |
| Tempest Therapeutics, Inc. | 24.83 Million USD | -1499.593% |
| Soleno Therapeutics, Inc. | 23.18 Million USD | -1613.505% |
| PepGen Inc. | 34.63 Million USD | -1047.12% |
| Moleculin Biotech, Inc. | 12.14 Million USD | -3171.237% |
| United Therapeutics Corporation | 1.18 Billion USD | 66.397% |
| Nuvectis Pharma, Inc. | 6.98 Million USD | -5588.13% |
| Solid Biosciences Inc. | 38.45 Million USD | -932.968% |
| BriaCell Therapeutics Corp. | 8.55 Million USD | -4542.399% |
| Immuneering Corporation | 12 Million USD | -3208.188% |
| Lixte Biotechnology Holdings, Inc. | 313.85 Thousand USD | -126472.845% |
| Silo Pharma, Inc. | 1.56 Million USD | -25214.892% |
| Belite Bio, Inc | 4.21 Million USD | -9333.84% |
| XOMA Corporation | 145.58 Million USD | -172.88% |
| ARS Pharmaceuticals, Inc. | 2.42 Million USD | -16261.573% |
| Bionomics Limited | 10.15 Million USD | -3810.522% |
| Apogee Therapeutics, Inc. | 21.49 Million USD | -1748.49% |
| Alpha Tau Medical Ltd. | 22.91 Million USD | -1633.771% |
| uniQure N.V. | 624.01 Million USD | 36.339% |
| Cassava Sciences, Inc. | 14.19 Million USD | -2698.584% |
| Estrella Immunopharma, Inc. | 180.7 Thousand USD | -219743.277% |
| Poseida Therapeutics, Inc. | 170.18 Million USD | -133.429% |
| Forte Biosciences, Inc. | 3.66 Million USD | -10736.307% |
| Anebulo Pharmaceuticals, Inc. | 260.58 Thousand USD | -152350.083% |
| Enlivex Therapeutics Ltd. | 6.74 Million USD | -5787.935% |
| Conduit Pharmaceuticals Inc. | 7.68 Million USD | -5071.97% |
| SeaStar Medical Holding Corporation | 17.38 Million USD | -2185.33% |
| FibroBiologics, Inc. Common Stock | 10.56 Million USD | -3659.075% |
| Altimmune, Inc. | 16.54 Million USD | -2301.663% |
| Amicus Therapeutics, Inc. | 617.7 Million USD | 35.688% |
| Alpha Tau Medical Ltd. | 22.91 Million USD | -1633.771% |
| Compugen Ltd. | 55.77 Million USD | -612.253% |
| Peak Bio, Inc. | 20.75 Million USD | -1814.191% |
| Zevra Therapeutics, Inc. | 110.46 Million USD | -259.631% |
| Benitec Biopharma Inc. | 4.96 Million USD | -7906.026% |
| Spyre Therapeutics, Inc. | 157.84 Million USD | -151.68% |
| NKGen Biotech, Inc. Common Stock | 75.17 Million USD | -428.453% |
| Zura Bio Limited | 21.29 Million USD | -1765.766% |
| PolyPid Ltd. | 17.46 Million USD | -2174.21% |
| Aileron Therapeutics, Inc. | 112.39 Million USD | -253.436% |
| NKGen Biotech, Inc. Warrants | 75.17 Million USD | -428.453% |
| Instil Bio, Inc. | 99.8 Million USD | -298.051% |
| argenx SE | 444.95 Million USD | 10.718% |
| Immunome, Inc. | 28.65 Million USD | -1286.206% |
| Compass Therapeutics, Inc. | 8.33 Million USD | -4665.011% |
| Verona Pharma plc | 58.84 Million USD | -575.14% |
| enGene Holdings Inc. Warrants | 14.47 Million USD | -2644.828% |
| Shattuck Labs, Inc. | 14.85 Million USD | -2573.524% |
| CervoMed Inc. | 2.59 Million USD | -15204.226% |
| LENZ Therapeutics, Inc. | 4.87 Million USD | -8050.574% |
| Plus Therapeutics, Inc. | 12.73 Million USD | -3019.182% |
| Dianthus Therapeutics, Inc. | 10.53 Million USD | -3670.85% |
| Moolec Science SA | 13.94 Million USD | -2748.683% |
| Enveric Biosciences, Inc. | 2.34 Million USD | -16851.497% |
| Inovio Pharmaceuticals, Inc. | 55.59 Million USD | -614.555% |
| AnaptysBio, Inc. | 364.28 Million USD | -9.051% |
| Design Therapeutics, Inc. | 11.95 Million USD | -3222.675% |
| Leap Therapeutics, Inc. | 12.68 Million USD | -3031.969% |
| NeurAxis, Inc. | 1.91 Million USD | -20669.117% |
| Seelos Therapeutics, Inc. | 38.92 Million USD | -920.497% |
| Lumos Pharma, Inc. | 13.33 Million USD | -2879.517% |
| Achilles Therapeutics plc | 19.08 Million USD | -1981.307% |
| enGene Holdings Inc. Common Stock | 14.47 Million USD | -2644.828% |
| 180 Life Sciences Corp. | 5.38 Million USD | -7274.115% |
| Opiant Pharmaceuticals, Inc. | 23.58 Million USD | -1584.158% |
| CERo Therapeutics Holdings, Inc. | 22.75 Million USD | -1645.447% |
| Nutriband Inc. | 1.07 Million USD | -36720.095% |
| ORIC Pharmaceuticals, Inc. | 30.59 Million USD | -1198.317% |
| CG Oncology, Inc. Common stock | 14.51 Million USD | -2637.64% |
| Fractyl Health, Inc. Common Stock | 401.27 Million USD | 1.001% |
| Rani Therapeutics Holdings, Inc. | 32.47 Million USD | -1123.352% |
| MoonLake Immunotherapeutics | 13.04 Million USD | -2944.341% |
| Palisade Bio, Inc. | 2.73 Million USD | -14403.797% |
| Tourmaline Bio, Inc. | 5.25 Million USD | -7462.517% |
| Beam Therapeutics Inc. | 478.38 Million USD | 16.958% |
| Neurogene Inc. | 36.54 Million USD | -986.922% |
| Mirum Pharmaceuticals, Inc. | 397.95 Million USD | 0.174% |
| AEON Biopharma, Inc. | 159.88 Million USD | -148.459% |
| CARGO Therapeutics, Inc. Common Stock | 47.65 Million USD | -733.702% |
| Sesen Bio, Inc. | 30.98 Million USD | -1182.142% |
| Enliven Therapeutics, Inc. | 25.96 Million USD | -1430.215% |
| Kiora Pharmaceuticals, Inc. | 7.6 Million USD | -5125.568% |
| Iovance Biotherapeutics, Inc. | 195.73 Million USD | -102.954% |
| Taysha Gene Therapies, Inc. | 192.05 Million USD | -106.844% |
| Athira Pharma, Inc. | 30.05 Million USD | -1221.685% |
| Vaccinex, Inc. | 5.94 Million USD | -6585.611% |
| HCW Biologics Inc. | 15.05 Million USD | -2539.254% |
| XOMA Corporation | 145.58 Million USD | -172.88% |
| Nektar Therapeutics | 267.04 Million USD | -48.761% |
| Arvinas, Inc. | 644.6 Million USD | 38.371% |
| Tevogen Bio Holdings Inc. | 17.73 Million USD | -2140.208% |
| Merus N.V. | 102.15 Million USD | -288.894% |
| Omega Therapeutics, Inc. | 146.35 Million USD | -171.444% |
| Quince Therapeutics, Inc. | 95.12 Million USD | -317.64% |
| Rezolute, Inc. | 11.73 Million USD | -3285.538% |
| Clene Inc. | 38.95 Million USD | -919.894% |
| Indaptus Therapeutics, Inc. | 2.84 Million USD | -13851.738% |
| BeyondSpring Inc. | 48.26 Million USD | -723.011% |
| Synlogic, Inc. | 32.89 Million USD | -1107.658% |
| Allarity Therapeutics, Inc. | 14.61 Million USD | -2618.531% |
| Phio Pharmaceuticals Corp. | 1.63 Million USD | -24212.056% |
| Peak Bio, Inc. | 20.75 Million USD | -1814.191% |
| Werewolf Therapeutics, Inc. | 63.45 Million USD | -526.009% |
| Krystal Biotech, Inc. | 39.71 Million USD | -900.3% |
| Karyopharm Therapeutics Inc. | 376.64 Million USD | -5.473% |
| SpringWorks Therapeutics, Inc. | 99.56 Million USD | -298.979% |
| Lipella Pharmaceuticals Inc. | 432.72 Thousand USD | -91703.82% |
| MannKind Corporation | 721.36 Million USD | 44.93% |
| Ikena Oncology, Inc. | 22.33 Million USD | -1678.639% |
| Cyclerion Therapeutics, Inc. | 2.08 Million USD | -18944.056% |
| Gyre Therapeutics, Inc. | 102.59 Million USD | -287.23% |
| Gossamer Bio, Inc. | 249.14 Million USD | -59.448% |
| CohBar, Inc. | 1.03 Million USD | -38333.088% |
| Cognition Therapeutics, Inc. | 10.68 Million USD | -3616.522% |
| NRx Pharmaceuticals, Inc. | 19.04 Million USD | -1985.568% |
| Legend Biotech Corporation | 589.93 Million USD | 32.66% |
| Mural Oncology plc | 37.92 Million USD | -947.403% |
| Biora Therapeutics, Inc. | 132.63 Million USD | -199.511% |
| PaxMedica, Inc. Common Stock | 2.29 Million USD | -17207.257% |
| Disc Medicine, Inc. | 22.87 Million USD | -1636.651% |
| Champions Oncology, Inc. | 28.03 Million USD | -1317.011% |
| REGENXBIO Inc. | 262.22 Million USD | -51.494% |
| Ensysce Biosciences, Inc. | 3.35 Million USD | -11725.465% |
| Anavex Life Sciences Corp. | 12.53 Million USD | -3069.451% |
| Cellectar Biosciences, Inc. | 13.43 Million USD | -2857.639% |
| Edgewise Therapeutics, Inc. | 21.2 Million USD | -1773.421% |
| Vaxart, Inc. | 34.02 Million USD | -1067.55% |
| PharmaCyte Biotech, Inc. | 20.38 Million USD | -1848.373% |
| Aldeyra Therapeutics, Inc. | 28.53 Million USD | -1292.334% |
| Cellectis S.A. | 249.57 Million USD | -59.174% |
| Longeveron Inc. | 5.33 Million USD | -7343.489% |
| Repare Therapeutics Inc. | 41.81 Million USD | -849.949% |
| Sarepta Therapeutics, Inc. | 2.4 Billion USD | 83.484% |
| Inozyme Pharma, Inc. | 60.36 Million USD | -558.062% |
| Revolution Medicines, Inc. | 262.39 Million USD | -51.396% |
| Nymox Pharmaceutical Corporation | 2.1 Million USD | -18754.248% |
| Third Harmonic Bio, Inc. | 8.62 Million USD | -4505.367% |
| ArriVent BioPharma, Inc. Common Stock | 11.8 Million USD | -3266.316% |
| AN2 Therapeutics, Inc. | 14.04 Million USD | -2728.876% |
| Anixa Biosciences, Inc. | 2.15 Million USD | -18368.573% |
| Vertex Pharmaceuticals Incorporated | 5.14 Billion USD | 92.286% |
| Denali Therapeutics Inc. | 122.96 Million USD | -223.072% |
| Revelation Biosciences, Inc. | 5.56 Million USD | -7038.662% |
| Veru Inc. | 32.81 Million USD | -1110.686% |
| Corvus Pharmaceuticals, Inc. | 6.86 Million USD | -5683.36% |
| Cingulate Inc. | 10.36 Million USD | -3734.226% |
| Passage Bio, Inc. | 39.26 Million USD | -911.815% |
| Context Therapeutics Inc. | 4.19 Million USD | -9377.243% |
| Exicure, Inc. | 8.54 Million USD | -4546.848% |
| Day One Biopharmaceuticals, Inc. | 29.5 Million USD | -1246.276% |
| Oramed Pharmaceuticals Inc. | 10.48 Million USD | -3688.47% |
| Scinai Immunotherapeutics Ltd. | 22.04 Million USD | -1702.364% |
| Rhythm Pharmaceuticals, Inc. | 162.98 Million USD | -143.738% |
| Nuvalent, Inc. | 31.82 Million USD | -1148.339% |
| ABVC BioPharma, Inc. | 6.36 Million USD | -6144.613% |
| Carisma Therapeutics, Inc. | 63.02 Million USD | -530.35% |
| Unicycive Therapeutics, Inc. | 18 Million USD | -2106.994% |
| OmniAb, Inc. | 87.4 Million USD | -354.53% |
| Anew Medical, Inc. | 8.24 Million USD | -4720.052% |
| Fennec Pharmaceuticals Inc. | 38.28 Million USD | -937.525% |
| Lipocine Inc. | 2.63 Million USD | -14995.555% |
| Lexeo Therapeutics, Inc. Common Stock | 26.27 Million USD | -1412.1% |
| Nautilus Biotechnology, Inc. | 40.21 Million USD | -887.912% |
| SAB Biotherapeutics, Inc. | 26.64 Million USD | -1391.111% |
| G1 Therapeutics, Inc. | 86.15 Million USD | -361.103% |
| Bellerophon Therapeutics, Inc. | 5.4 Million USD | -7255.286% |
| Sage Therapeutics, Inc. | 82.74 Million USD | -380.089% |
| Ocugen, Inc. | 23.98 Million USD | -1556.419% |
| Mind Medicine (MindMed) Inc. | 46.4 Million USD | -756.032% |
| Q32 Bio Inc. | 233.12 Million USD | -70.404% |
| Brainstorm Cell Therapeutics Inc. | 9.06 Million USD | -4281.855% |
| Alumis Inc. Common Stock | 53.5 Million USD | -642.512% |
| Equillium, Inc. | 27.95 Million USD | -1320.964% |
| Kyverna Therapeutics, Inc. | 206.59 Million USD | -92.292% |
| Coya Therapeutics, Inc. | 5.62 Million USD | -6960.292% |
| CNS Pharmaceuticals, Inc. | 6.13 Million USD | -6377.435% |
| Galera Therapeutics, Inc. | 157.32 Million USD | -152.507% |
| Evelo Biosciences, Inc. | 69.43 Million USD | -472.147% |
| Comera Life Sciences Holdings, Inc. | 9.97 Million USD | -3882.865% |
| Dominari Holdings Inc. | 4.63 Million USD | -8470.852% |
| Edesa Biotech, Inc. | 1.84 Million USD | -21470.972% |
| vTv Therapeutics Inc. | 29.56 Million USD | -1243.589% |
| Bio-Techne Corporation | 744.34 Million USD | 46.629% |
| Agios Pharmaceuticals, Inc. | 126.09 Million USD | -215.037% |
| Harmony Biosciences Holdings, Inc. | 344.45 Million USD | -15.329% |
| Prelude Therapeutics Incorporated | 40.57 Million USD | -879.073% |
| Candel Therapeutics, Inc. | 28.95 Million USD | -1271.893% |
| iTeos Therapeutics, Inc. | 92.36 Million USD | -330.12% |
| Nkarta, Inc. | 105.6 Million USD | -276.192% |
| BioCardia, Inc. | 4.59 Million USD | -8554.88% |
| Iterum Therapeutics plc | 32.66 Million USD | -1116.273% |